Key result
Home telerehabilitation improves 6MWT distance by ~35 meters vs usual care in HF and diabetes.
Why the study?
Heart failure and type 2 diabetes represent significant public health concerns, prompting evaluation of a 6-month home-based telemedicine program for older patients with both conditions.
Does a 6-month home-based telerehabilitation program improve exercise tolerance in older patients with combined chronic heart failure and type 2 diabetes?
RCT (n=163)
Does a 6-month home-based telerehabilitation program improve exercise tolerance in older patients with combined chronic heart failure and type 2 diabetes?
Absolute Event Rate: 12.4% vs -22.4%
p-value: p=0.0001
A 6-month home-based telerehabilitation program significantly improved exercise tolerance and physical activity profiles in elderly patients with concurrent heart failure and type 2 diabetes compared to usual care.
No takes yet. Share an insight, caveat, or question.
Supports home-based telerehabilitation to improve exercise tolerance in older HF-T2D patients; extends RCT evidence to this comorbid group.
Scalvini et al. (2026) conducted an RCT in Chronic heart failure and type 2 diabetes (n=163). Home-based telemedicine program (teleassistance, telemonitoring, and app) vs. Usual care was evaluated on Exercise tolerance evaluated at the 6-minute walk test (6MWT) (p=0.0001). A 6-month home-based telerehabilitation program significantly improved 6-minute walk test distance (+12.4m vs -22.4m; p=0.0001) compared to usual care in patients with heart failure and diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: